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Abstract 
Import of proteins into the glycosomes of 7Y brucei resembles the peroxisomal protein import in that C-terminal SKL-like tripeptide sequences 
can function as targeting signals. Many of the glycosomal proteins do not, however, possess such C-terminal tripeptide signals. Among these, 
phosphoenolpyruvate carboxykinase (PEPCK (ATP)) was thought to be targeted to the glycosomes by an N-terminal or an internal targeting signal. 
A limited similarity to the N-terminal targeting signal of rat peroxisomal thiolase exists at the N-terminus of 7: brucei PEPCK. However, we found 
that this peroxisomal targeting signal does not function for glycosomal protein import in Z brucei. Further studies of the PEPCK gene revealed that 
the C-terminus of the predicted protein does not correspond to the previously deduced protein sequence of 472 amino acids due to a -1 frame shift 
error in the original DNA sequence. Readjusting the reading frame of the sequence results in a predicted protein of 525 amino acids in length ending 
in a tripeptide serine-arginine-leucine (SRL), which is a potential targeting signal for import into the glycosomes. A fusion protein of firefly luciferase, 
without its own C-terminal SKL targeting signal, and 7: brucei PEPCK is efficiently imported into the glycosomes when expressed in procyclic 
trypanosomes. Deletion of the C-terminal SRL tripeptide or the last 29 amino acids of PEPCK reduced the import only by about 50% while a deletion 
of the last 47 amino acids completely abolished the import. These results suggest hat 7: brucei PEPCK may contain a second, internal glycosomal 
targeting signal upstream of the C-terminal SRL sequence. 
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1. Introduction 
In the bloodstream form of Trypanosoma brucei, 
which lacks a fully functional mitochondrion, energy is 
supplied primarily by glycolysis. Most of the glycolytic 
enzymes are confined within a set of membrane-bound 
organelles, designated the glycosomes [11. Morphologi- 
cally, the glycosomes closely resemble the peroxisomes 
found in higher eukaryotes, although their enzyme con- 
tents differ significantly [2]. Recent studies indicated that 
the import of proteins into the glycosome depends on a 
conserved C-terminal tripeptide motif, analogous to the 
C-terminal serine-lysine-leucine (SKL) sequence respon- 
sible for peroxisomal targeting of firefly luciferase [3,4]. 
Subsequent investigations showed that the C-terminal 
tripeptide sequence requirements for glycosomal import 
are considerably more relaxed than those for import of 
proteins into mammalian peroxisomes [3-51. Among the 
seven glycosomal proteins of T brucei that have been 
sequenced, three are likely to have a C-terminal tripep- 
tide targeting signal. Glyceraldehyde-3-phosphate d hy- 
drogenase and glucosephosphate isomerase nd in AKL 
and SHL, respectively [6,7], while 3-phosphoglycerate 
kinase uses a C-terminal SSL sequence as targeting sig- 
nal [5]. However, the other four glycosomal proteins, 
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phosphoenolpyruvate carboxykinase (PEPCK) [8,9], tri- 
osephosphate isomerase [lo], the 56 kDa phosphoglycer- 
ate kinase [ 1 l] and aldolase [121 do not end in a tripeptide 
sequence that could qualify as a glycosomal targeting 
signal. These proteins must depend on other import sig- 
nals in order to enter the glycosomes. 
A small number of peroxisomal proteins are targeted 
to the microbody by peptide sequences near the N-termi- 
nus of the protein [13-161. Among these, rat 3-ketoacyl- 
CoA thiolase is targeted to the mammalian peroxisome 
by a cleavable N-terminal presequence [ 13,17,18], appar- 
ently using an import mechanism that is distinct from the 
C-terminal tripeptide recognition system [19]. Swinkels 
et al. [13] have shown that the first 11 amino acids of the 
rat thiolase B isozyme precursor are sufficient to target 
the cytosolic protein chloramphenicol acetyltransferase 
(CAT) to the peroxisome when present at the N-termi- 
nus. Since a limited similarity to this thiolase prese- 
quence exists near the N-termini of T brucei aldolase 
and PEPCK, we tested the possibility that the same thio- 
lase targeting signal may also function in glycosomal 
protein import. The 11 amino acids of the thiolase were 
thus added to the N-termini of chloramphenicol ace- 
tyltransferase (CAT) and /I-glucuronidase (GUS), but 
these fusion proteins failed to enter the glycosomes in 
vivo, suggesting that the thiolase N-terminal signal does 
not function in 7: brucei. 
The i’Y brucei PEPCK gene reportedly encodes a protein 
of 472 amino acids with a molecular mass of 52.5 kDa 
[8,9]. However, during our studies we found an apparent 
sequencing error in the PEPCK gene. Readjusting the 
126 
reading frame of the sequence results in a predicted pro- 
tein of 525 amino acids ending in the tripeptide SRL. 
Further examinations verified that this is indeed the 
major glycosomal targeting signal of PEPCK, although 
the upstream sequence of about 50 amino acids may also 
play an important role in glycosomal import. 
2. Materials and methods 
2.1. N-terminal thiolase fusion constructs 
The thiolase-CAT fusion construct was made by PCR amplification 
of the CAT gene in the plasmid pJP25 [3] with an N-terminal PCR 
primer encoding the first 15 amino acids of the rat 3-ketoacyl-CoA 
thiolase B gene [20]. The thiolase-GUS fusion construct was made by 
PCR amplification of the GUS gene in pGUSN358-+S (Clontech Lab- 
oratories, Inc., Palo Alto, CA) with a 5’ PCR primer in which the start 
codon of the GUS gene was replaced by the first 11 amino acids of the 
rat thiolase gene. Both PCR fragments were inserted into the cloning 
site of the TA vector (Invitrogen, San Diego, CA) and subsequently 
transferred as Hind111 to BamHl fragments into the 7: brucei expres- 
sion vector pTSA-HYG2 [5]. 
2.2. PEPCKfusion constructs 
The 7: brucei PEPCK gene, a generous gift from Dr. Thomas 
Seebeck, was purified as an XhoI fragment from the plasmid pTbp60B 
[8] and inserted into pBluescript (PBS+) (Stratagene, San Diego, CA), 
with the downstream Hind111 site of PEPCK closest to the Hind111 site 
in PBS. A Not1 site was introduced at the start of the PEPCK coding 
region by site-directed mutagenesis (Amersham System Version 2.0, 
Amersham, Arlington Height, IL.). The open reading frame of the 
luciferase gene in the expression vector pLUH207 lacks the last nine 
nucleotides encoding the SKL tripeptide (IuciferasedSKL), which were 
replaced by NotI, StuI and SnaBI sites, followed by stop &dons in each 
reading frame. uLUH207 is essentiallv identical to uLUH206 151. exceut 
that a four bask pair GATC sequence immediately preceding the luc;f- 
erase coding region was removed in pLUH207 by site-directed mut- 
agenesis for the construction of some of the N-terminal fusions. The 
1,440 bp NotI-Hind111 fragment containing the first 478 amino acids 
of PEPCK gene was inserted downstream of the luciferase gene in 
pLUH207, cut with Not1 and StuI, resulting in the IuciferasedSKL- 
PEPCK478. The truncated PEPCK gene is immediately followed by a 
stop codon in the vector sequence. To produce the luciferase-PEPCK 
fusion gene containing the full length PEPCK. the 1.875 bu NotI-DraI 
fragment was insertedinto pLUHZ07 cut with’Not1 and &I. To delete 
the C-terminal SRL sequence from the PEPCK protein, the full-length 
gene was amplified by the polymerase chain reaction (PCR) using a 
mutagenic C-terminal primer which introduced a stop codon at amino 
acid position 523. The PCR fragment was then used to replace the 
PEPCK gene in the above luciferasedSKL-PEPCK fusion construct. 
The IuciferasedSKL-PEPCK496 construct was made by truncating the 
PEPCK gene at a unique Ear1 site, filling in the recessed end with 
Klenow and ligation to the downstream StuI site. This resulted in 
addition of a proline and a threonine residue between phenylalanine 496 
of PEPCK and the stop codon. 
2.3. Transformation of T. brucei and subcellular localization of 
reporter protein 
Linearized plasmid DNA was introduced into procyclic j? brucei 
TREU667 cells by electroporation [3], and stable transformants were 
isolated as described previously [3]. Subcellular localization of the lucif- 
erase or GUS reporter proteins was determined by differential dig- 
itonin-solubilization of either transiently transfected cells or stable 
transformants by a previously described procedure [3, 51. 
For the Proteinase K treatment, approximately 5 x IO6 7: brucei 
procyclic cells were treated with 4 fig digitonin in a 200 ~1 volume of 
HEDS + KOAc buffer [21]. Proteinase K was added to a final concen- 
tration of 250 &ml and the mixture was incubated at room tempera- 
ture for 30 min. Phenylmethanesulfonyl fluoride (PMSF) was added to 
2 mM and the remaining luciferase activity was assayed immediately. 
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3. Results and discussion 
3.1. The N-terminal presequence of peroxisomal thiolase 
does not function in glycosomal import 
We added the 11 amino acid portion of the rat 
3-ketoacyl-CoA thiolase presequence (-26 to - 16) to the 
N-termini of CAT and GUS. The resulting thiolasee 
CAT fusion protein was thus identical to that shown to 
be imported into the mammalian peroxisome by 
Swinkels et al. [13]. The subcellular distribution of the 
fusion proteins was determined by assaying for CAT or 
GUS activity in the supernatant and pellet fractions fol- 
lowing in vivo expression of the fusion genes in trans- 
formed procyclic trypanosomes and solubilization of the 
plasma membrane by digitonin [3,5]. These experiments 
showed that in both cases the enzyme activity was lo- 
cated in the cytoplasm (Data not shown), leading us to 
conclude that the thiolase N-terminal peroxisomal tar- 
geting signal does not function or is not sufficient for 
import of proteins into the glycosomes. 
3.2. Fusion constructs containing the PEPCKprotein at 
the N-termini are not expressed in T. brucei 
To test for the presence of a potential N-terminal tar- 
geting signal in r brucei PEPCK, we made fusion con- 
structs containing the 472 amino acids of the PEPCK 
protein at the N-termini of GUS and firefly luciferase, 
TCGA 
I I I I 
Fig. I. DNA sequence surrounding amino acid position 458 of the 
. 
T brucei PEPCK gene. Four sequential guanosine residues were re- 
solved by double-stranded sequencing of plasmid DNA using a ther- 
mostable polymerase and high temperature sequencing (Circumvent, 
New England Biolabs, Beverly, MA). The sequence from top to bottom 
specifies TAT (Tyr45’) GAA (G~u~~*) GTG (Va145’) TAT (Tyr45”) CCC 
(Pro4”) CGA (Glyo6) TGG (Trp4”) GGC (GIY~‘~) CTT (Leu459) and 
CAC (His460). 
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Fig. 2. Amino acid sequence alignment of PEPCK from Succharomyces cerevisiae, 7: brucei and 7: cruzi. Optimal alignment of the S. cerevisiae and 
7: brucei PEPCK (ATP) protein sequences (GenBank Accession Nos. X1306 and A33275) was computed at the EMBL (Heidelberg) using the FASTA 
network service. Alignment of the 7? brucei and 7: crzrzi (GenBank Accession No. A33275) sequences was performed using MBIR software. The 
C-termini of the published ?: brucei and 7: cruzi sequences are indicated in parentheses. The arrow indicates the position of the frame shift. 
which had its own C-terminal SKL targeting signal de- 
leted (1uciferasedSKL). The in vivo expression of these 
fusion constructs did not result in any measurable GUS 
or luciferase activity, and we were unable to detect the 
fusion proteins by Western blotting (data not shown). 
Further examination of these constructs showed that the 
downstream reporter proteins were not in the same read- 
ing frame as the PEPCK protein (see below). 
3.3. Determination of the C-terminal sequence of PEPCK 
The originally predicted ZY brucei PEPCK protein of 
472 amino acids ends in the tripeptide glutamine-alanine- 
cysteine [8,9], which is unlikely to function as a gly- 
cosomal import signal by our previous analysis of tripep- 
tide targeting signals [3]. However, upon resequencing of 
the PEPCK gene, corresponding to amino acid position 
458, we found four sequential guanosine residues instead 
of three, as previously reported (Fig. 1). This shift in the 
reading frame at the C-terminus of PEPCK thus explains 
the lack of expression or activities of the reporter en- 
zymes from the PEPCK-luciferase fusion constructs. The 
length of the newly deduced PEPCK protein increases 
from 472 to 525 amino acids with a calculated molecular 
mass of 58.6 kDa, which is close to the 60 kDa molecular 
128 
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Fig. 3. Digitonin solubilization of 1uciferaseePEPCK fusion proteins. 
Cell cultures were transiently transfected with plasmids encoding either 
wild type luciferase (o), IuciferasedSKL (o), the fusion proteins lucif- 
erasedSKL-PEPCK525 (A), luciferase&KL-PEPCK522 (A), lucif- 
erasedSKL_PEPCK496 (0) or IuciferasedSKL-PEPCK478 (m). solu- 
bilked at increasing concentrations of digitonin, centrifuged and 
assayed for luciferase activity in the pellet and supernatant fractions. 
weight of 7: brucei PEPCK estimated by SDS-poly- 
acrylamide gel electrophoresis [8]. The newly derived 
protein sequence following amino acid 458 also shows 
significant homology to the PEPCK (ATP) of Saccharo- 
myces cerevisiue (Fig. 2). The longer protein ends in the 
tripeptide serine-arginine-leucine (SRL), which had been 
previously identified as a functional glycosomal target- 
ing signal when present at the C-terminus of luciferase 
[31. 
3.4. The h&erase-PEPCK fusion protein is imported 
into the glycosomes 
Following in vivo expression of a plasmid construct 
containing the full length PEPCK gene sequence down- 
stream of luciferase (lucdSKL-PEPCK525), more than 
90% of the luciferase activity remained in the pellet frac- 
tion at digitonin concentrations which are known to 
completely solubilize the cytoplasmic proteins (Fig. 3) 
indicating possible import of the fusion protein into the 
glycosomes. The wild type luciferase was also found in 
the pellet fraction under the same conditions (Fig. 3) and 
we have previously shown by electron microscopy that 
this protein is imported into the glycosomes [3,5]. 
Proteins that are inside an intact, membrane-bound 
organelle are expected to be protected from externally 
added proteases. We thus treated the digitonin-permea- 
bilized procyclic transformants with Proteinase K at 250 
pug/ml, which inactivates native luciferase and luciferase 
fusion proteins in the presence of 0.2% Triton X-100 
(Fig. 4). In each case, the digitonin-insoluble luciferase 
activity was highly resistant to Proteinase K treatment, 
but completely lost when Triton X-100 was included 
(Fig. 4). The luciferasedSKL-PEPCK525 fusion protein 
was equally resistant to Proteinase K as the wild type 
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luciferase, and also became susceptable to Proteinase K 
digestion in the presence of Triton X-100. It is thus most 
likely imported into the 7: brucei glycosomes. 
3.5. The C-terminal tripeptide of PEPCK is required jbr 
ef$cient glycosomal import 
In order to show that the C-terminal SRL sequence of 
PEPCK is specifically required for glycosomal targeting, 
we expressed a fusion construct lacking the SRL se- 
quence (luciferasedSKL-PEPCK522). In this case, 
about 50% of the luciferase activity was digitonin solu- 
ble, indicating that it was present in the cytoplasm, while 
the remainder may be imported into the glycosome (Fig. 
3). Thus, the C-terminal SRL sequence of T brucei 
PEPCK is indeed required for efficient import of the 
protein into the glycosomes. The digitonin-insoluble 
fraction of the luciferase activity was also resistant to 
Proteinase K digestion (Fig. 4) confirming that it was 
most likely inside the glycosome. These results suggest 
that 7: brucei PEPCK may contain another targeting 
signal in addition to its C-terminal SRL sequence. In our 
earlier efforts to produce a luciferasedSKL-PEPCK fu- 
sion construct, we made use of a Hind111 endonuclease 
restriction site located 8 nt downstream of the wrongly 
presumed stop codon, which resulted in a truncation of 
the actual C-terminus of PEPCK by 47 amino acids. This 
fusion protein (luciferasedSKL-PEPCK478) was found 
exclusively in the cytoplasm of 7: brucei and was sensi- 
tive to Proteinase K. An additional construct lacking 
IucASKL 
IucASKL-PEPCK525 
IucASKL-PEPCK522 
IucASKL-PEPCK496 
IucASKL-PEPCK478 
0 20 40 60 80 100 
ProteinaseK-resistant 
luciferase activity (%) 
Fig. 4. Proteinase K treatment of digitonin-permeabilized transfor- 
mants expressing luciferase fusion proteins. Stable procyclic transfor- 
mants were incubated with 0.25 mg per ml Proteinase K in the presence 
of digitonin (hatched bars) or digitonin and Triton X-100 (solid bars) 
for 30 min at room temperature. In each case, the remaining luciferase 
activity was plotted as percent of enzyme activity in the absence of 
Proteinase K. 
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only the last 29 amino acids of PEPCK (luciferasedSKL- 
PEPCK496) is, however, partially imported into the gly- 
cosomes (Figs. 3 and 4). This observation raises the pos- 
sibility that essential elements of a second targeting 
signal may be contained between amino acids 478 and 
496 of PEPCK, approximately 40 amino acids upstream 
of the C-terminal SRL tripeptide. However, it is also 
possible that some of these deletions affect the overall 
structure of the protein and thus alter context- or struc- 
ture- dependent targeting signals present in the remain- 
der of the protein [22]. The possibility that the fusion 
proteins containing 496 and 522 amino acids of PEPCK 
are partially digitonin-insoluble and protease-resistant 
due to aggregation is unlikely, since they are completely 
soluble and digestable by Proteinase K at low concentra- 
tions of Triton X-100 and preliminary immunoelectron 
microscopy data indicates that much of the lucif- 
erasedSKL-PEPCK522 is found inside the glycosomes 
(Data not shown). Catalase A, a major peroxisomal pro- 
tein of Saccharomyces cerevisiae, was found to contain 
two independently functioning targeting signals, one of 
which is an internal signal, which could not be precisely 
mapped, and the other a C-terminal SKF sequence [22]. 
Further investigations with localized mutagenesis of the 
PEPCK protein will determine if the sequence between 
amino acids 478 and 496 indeed contains a genuine gly- 
cosomal targeting signal. 
The gene encoding PEPCK from a related trypanoso- 
matid species, Trypanosoma cruzi, has also been cloned 
and sequenced recently [23]. Interestingly, the deduced 
amino acid sequence of the T cruzi PEPCK protein 
appears to contain the same frame shift error at amino 
acid position 458, resulting from a missing guanosine 
nucleotide in the DNA sequence. By inserting an extra 
guanosine at the position corresponding to amino acid 
458 in the 1: cruzi gene, the predicted protein sequence 
also extends to a length of 525 amino acids. Alignment 
of the corrected 7: brucei and 7: cruzi protein sequences 
restores their C-terminal homology to 74% identity, with 
85% identity over the entire length of the two PEPCK 
proteins (Fig. 2). These changes do not affect the consen- 
sus phosphate and adenine binding sites around amino 
acids 224 and 333, or the putative divalent cation binding 
site at position 253 of the PEPCK (ATP) [23]. The re- 
vised 7: cruzi PEPCK protein sequence ends in the 
tripeptide ARL, which is also expected to be responsible 
for its glycosomal import in iY cruzi [3]. 
In summary, we have shown that the N-terminal pre- 
sequence of peroxisomal thiolase does not function for 
import of proteins into T brucei glycosomes, although 
this N-terminal peroxisomal targeting signal has been 
well conserved between mammalian cells, plants and 
fungi [17,18,24,25]. However, we cannot rule out the 
possibility that a related variant of this signal also func- 
tions for import of some proteins into the glycosomes of 
7: brucei . The PEPCK genes of 7: brucei and 7: cruzi 
129 
each encode proteins of 525 amino acids with calculated 
molecular masses of 58.6 and 58.9 kDa, respectively. The 
SRL and ARL sequences at the C-termini of these pro- 
teins are most likely involved in the glycosomal targeting 
of these enzymes, but 7: brucei PEPCK may also contain 
a second, internal targeting signal, about 40 amino acids 
upstream of the C-terminus. 
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